{"disease":{"id":"multiple-drug-use","name":"multiple drug use"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04261504","title":"Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Texas Tech University","has_results":true},{"nct_id":"NCT06324786","title":"Brain Mechanisms of Reducing Polysubstance Use","phase":"NA","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"Arizona State University","has_results":false},{"nct_id":"NCT06214130","title":"Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Desitin Arzneimittel GmbH","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}